Stem Cell in Cardiovascular Disease
Stem cell therapy in cardiovascular illness focuses on repairing heart tissue and enhancing heart function. By introducing stem cells into the heart, researchers aim to regenerate cardiac muscle, reduce scarring, and boost blood flow. Clinical trials have shown encouraging outcomes, suggesting that stem cell treatments could significantly improve the management and recovery of heart disease patients.
Related Conference of Stem Cell in Cardiovascular Disease
March 09-10, 2026
21th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
Singapore City, Singapore
June 18-19, 2026
16th International Conference on Human Genetics and Genetic Diseases
Singapore City, Singapore
June 18-19, 2026
19th International Conference on Genomics & Pharmacogenomics
Singapore City, Singapore
Stem Cell in Cardiovascular Disease Conference Speakers
Recommended Sessions
- Advanced Gene Therapeutics
- Cancer Therapies
- CAR T-cell Therapy
- Cell Culture and Bioprocessing
- Cell Science and Stem Cell Research
- Cellular Therapies
- Clinical Trials and Research in Cell and Gene Therapies
- Diabetes Gene Therapy
- Genetic Vaccines
- HIV Gene Therapy
- Human Gene Therapy
- Molecular Epigenetics
- Nano-Therapy
- Nanotechnology in Stem Cell
- Novel Stem Cell Therapy
- Skin Cell Therapy
- Stem Cell Engineering
- Stem Cell in Cardiovascular Disease
- Stem Cell in Drug Development
- Stem Cell Therapies
- Viral Gene Therapy
Related Journals
Are you interested in
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (France)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (France)
- Cancer Stem Cells and Oncology - Stemgen 2026 (France)
- Cardiovascular Regeneration - Stemgen 2026 (France)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (France)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (France)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (France)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (France)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (France)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (France)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (France)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (France)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (France)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (France)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (France)